Literature DB >> 14555322

Incidence and characteristics of myelodysplastic syndromes in Ourense (Spain) between 1994-1998.

Marina Iglesias Gallego, José Luis Sastre Moral, Pilar Gayoso Diz, Agustín García Costa, Santiago Ros Forteza, José Manuel Mayán Santos.   

Abstract

The very few reference epidemiological studies on myelodysplastic syndromes (MDS) have been carried out in Europe: Germany, France, UK and Sweden. We present the first Spanish study on the incidence and characteristics of MDS. The incidence rates, distribution by FAB subtypes, sex and age groups are within the ranges established by the reference studies with minimal differences which we point out and attempt to explain.

Entities:  

Mesh:

Year:  2003        PMID: 14555322

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  6 in total

Review 1.  Failure of hypomethylating agent-based therapy in myelodysplastic syndromes.

Authors:  Tapan M Kadia; Elias Jabbour; Hagop Kantarjian
Journal:  Semin Oncol       Date:  2011-10       Impact factor: 4.929

2.  Costs and quality of life in patients with myelodysplastic syndromes.

Authors:  Carlo Lucioni; Carlo Finelli; Silvio Mazzi; Esther N Oliva
Journal:  Am J Blood Res       Date:  2013-08-19

Review 3.  Role of epigenetic therapy in myelodysplastic syndrome.

Authors:  Tapan M Kadia; Guillermo Garcia-Manero
Journal:  Expert Rev Hematol       Date:  2008-12       Impact factor: 2.929

4.  Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys.

Authors:  Mikkael A Sekeres; W Marieke Schoonen; Hagop Kantarjian; Alan List; Jon Fryzek; Ronald Paquette; Jaroslaw P Maciejewski
Journal:  J Natl Cancer Inst       Date:  2008-10-28       Impact factor: 13.506

5.  Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain.

Authors:  Carlos Crespo; Estela Moreno; Jordi Sierra; Suzan Serip; Marta Rubio
Journal:  Health Econ Rev       Date:  2013-12-05

6.  The incidence of myelodysplastic syndromes in Western Greece is increasing.

Authors:  Christina Avgerinou; Yannis Alamanos; Panagiotis Zikos; Polyxeni Lampropoulou; Maria Melachrinou; Vassiliki Labropoulou; Ioannis Tavernarakis; Anthi Aktypi; Panagiotis Kaiafas; Christos Raptis; Alexandra Kouraklis; Marina Karakantza; Argiris Symeonidis
Journal:  Ann Hematol       Date:  2013-04-10       Impact factor: 3.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.